| Financial Year |
March 31 2023 |
| Monetary Funds |
740,331,052.88 |
| Held-for-trading Financial Assets |
89,977,929.99 |
| Notes Receivable |
2,667,326.15 |
| Accounts Receivable |
315,978,056.16 |
| Advances to Suppliers |
40,526,509.92 |
| Other Receivables |
25,304,968.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
306,229.77 |
| Dividend Receivable |
-- |
| Inventories |
585,985,800.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
154,069,458.93 |
| Total Current Assets |
1,959,315,449.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
44,804,297.61 |
| Investment Properties |
15,930,153.17 |
| Fixed Assetes |
778,794,646.22 |
| Under-construction Projects |
287,459,857.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
206,644,797.74 |
| R&D expenses |
9,438,842.77 |
| Goodwill |
5,287,234.56 |
| Long-Term Deferred and Prepaid Expenses |
32,794,812.90 |
| Deferred Income Tax Assets |
47,436,912.34 |
| Other Non-Current Assets |
54,265,164.53 |
| Sub-Total of Non-Current Assets |
1,783,555,658.90 |
| Total Assets |
3,742,871,108.36 |
| Short-Term Loans |
239,069,481.55 |
| Trading Financial liabilities |
304,521.63 |
| Notes Payable |
23,705,358.08 |
| Accounts Payable |
157,092,067.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
96,414,941.37 |
| Taxes Payable |
110,973,823.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
113,928,013.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,977,639.91 |
| Other Current Liabilities |
23,132,414.18 |
| Sub-Total of Current Liabilities |
969,216,029.84 |
| Long-term Loans |
214,406,809.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,793,545.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
259,648,685.49 |
| Total Liabilities |
1,228,864,715.33 |
| Paid-In Capital(Or Share Stock) |
567,000,000.00 |
| Capital Surplus |
392,714,732.75 |
| Surplus Reserve |
154,923,302.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,372,504,437.69 |
| Minority Stockholder's Interest |
14,631,372.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,499,375,020.36 |
| Owner's Equity（Stockholder's Equity） |
2,514,006,393.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,742,871,108.36 |
